Abstract: A process for the manufacture of drugs intended for the treatemt of obesity by using a reversible seleective inhibitor of monoamine oxidase A, reversible selective inhibitor of monoamine oxidase B or a reversible mixed inhibitor of monoamine oxidase4 A and B